Kursprognose für Chronoscale Corp (CHRN)CHRNChronoscale Corp

Alphio's CHRN stock price prediction model matches the current Chronoscale Corp tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $15.88 (+0.78%). The 1-week path is $16.30 (+3.42%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Currently, Ekso Bionics Holdings, Inc. (CHRN) is not a good buy. The stock is trading at $15.08, which is significantly below its analyst price target of $32, indicating potential upside. However, the RSI is at a low 26.447, suggesting it is oversold but also reflects weak momentum. The company has reported a staggering 18.88% decline over the past five days and a 26.15% drop over the last 20 days, indicating a bearish trend. The main risk is its net income, which has been consistently negative, with a recent report showing a loss of $42,484,000 in Q3 2026, raising concerns about its financial stability.

Chronoscale Corp (CHRN) last closed at $15.76, gaining +5.28%. These facts feed the 1-day and 1-week CHRN price prediction above.